Uppsala University PET Centre Per Hartvig, Uppsala University PET Centre Central dopaminergic and serotonergic function studied with positron emission.

Slides:



Advertisements
Similar presentations
Lecture 5 - Serotonin.
Advertisements

Chapter 5 Opener. 5.1 Structural features of catecholamines.
Catecholamines (dopamine [DA], norepinephrine [NE], epinephrine [EPI]) 1. Basic Neurochemistry, Chap The Biochemical Basis of Neuropharmacology,
What about communication between neurons?.  presynaptic ending – ◦ portion of the axon conveying information to the next neuron.
Neuronal Transmission
1. If a stimulus shifts the potential inside a neuron from the resting potential to a more negative potential, the result is __________. A) hyperpolarization.
Neurotransmitters Many Neurotransmitters (NT) exist: -Dopamine -Adrenaline -Serotonin -Acetylcholine Drugs can either: –Increase the effect of certain.
Neurotransmission and the CNS BY PROF. Azza El-Medany.
OCD. Neurochemical dysfunction (abnormalities in serotonin (5-HT), dopamine (DA), and glutamatergic transmitter systems) Neurochemical dysfunction (abnormalities.
Widely Found and Studied Neurotransmitters  Glutamate – has excitatory functions  4 Ascending activating systems are very important  Cholinergic System.
CHAPTER 6 IN THE SYLLABUS: Principles of Pharmacology Dr. Robert L. Patrick Department of Neuroscience Brown University Biomed.
Drugs on the Brain Emma Robinson RCUK Academic Fellow.
INHERİTED DİSEASES OF AMİNO ACİD METABOLİSM Prof.Dr.Arzu SEVEN 1.
Neurotransmitters in the Central Nervous System By Prof. A. Alhaider Dept. of Pharmacology.
B 尤思涵. Dopamine and Serotonin Dopamine 4-(2-aminoethyl)benzene-1,2-diol 5-Hydroxytryptamine or 3-(2-aminoethyl)-1H-indol-5-ol Serotonin.
Module 7.3 Movement Disorders. Parkinson’s Disease A neurological disorder characterized by muscle tremors, rigidity, slow movements and difficulty initiating.
DR AMINA TARIQ BIOCHEMISTRY
PHAR2811 Lecture Amino acids as drug targets COMMONWEALTH OF AUSTRALIA Copyright Regulation WARNING This material has been reproduced and communicated.
Receptors What!! There’s More??. Receptors are a very important part of Neurotransmission What we know….(or think we know) –The number of receptors and.
MicroPET: Radiotracer Imaging of Rodents and Non-Human Primates Alexander K. Converse, PhD University of Wisconsin–Madison Waisman Center - Brain Imaging.
Psychopharmacology The Study of the effects of drugs on the nervous system and behavior Drugs: – Exogenous chemical (not produced by the body) – Not necessary.
NEUROCHEMICAL EFFECTS OF STIMULANTS: Relation to their motor effects.
Positron Emission Tomography: Tool to Facilitate Drug Development and to Study Pharmacokinetics Robert B. Innis, MD, PhD Molecular Imaging Branch National.
Modulation pharmacoMRI to investigate the neural effects of SSRIs on emotional face processing A. E. ÉDES 1,2, D. KOVÁCS 1,2, D. PAP 1,2, X. GONDA 1,2,3,
Imaging Degenerative Diseases of the Brain Cathleen Kouvolo.
Introduction to CNS pharmacology
Neurotransmitters: Catecholamines & Acetylcholine Chapters 5 & 6
Salvador Dali (Painter) Mao Zedong (Chinese Politician) Michael J Fox (Actor) Pope John Paul II Muhammad Ali (Boxer) Janet Reno (Former AG)
Pharmacophysiology. ACTIONS OF ANTIDEPRESSANTS ON AMINE NEUROTRANSMITTERS The amine hypothesis Tricyclics block the amine transporters known as the.
Individual amino acids metabolism of clinical importance ط Overview of synthesis of some important products of amino acids : Phenylalanine, Tyrosine, Tryptophane,
Prepared by Grant McLaren, Department of Psychology, Edinboro University of Pennsylvania FOUNDATIONS OF BEHAVIORAL NEUROSCIENCE 9 TH EDITION This multimedia.
How do drugs affect the synapse?
Neuroscience and Behavior. 2 Neurons Neurons are similar to other cells in the body because: Neurons are surrounded by a cell membrane. Neurons have a.
Neurotransmitters & Receptors. Sensory neuron Motor neuron Receptor potentialAction potential Synaptic potential Action potential.
How are medicines developed?. What is it? What’s inside?
Biological Explanations for Schizophrenia
Neurotransmitters!. What is a neuron? Basic cells in the brain.
By Rahul Kapoor. Based on a study performed by Stephen McGowan MRCPsych Andrew D. LawrenceMRCPsych Tim Sales MRCPsych Digby Quested MRCPsych Paul Grasby.
Neurotransmitters: Monoamines
Unit 3 – Neurobiology and Communication
Produced from adrenal glnad content: Epinephrine (adrenaline) Nor epinephrine(nor adrenaline) Dopamine.
Pharmacology of central Neurotransmitters Prof. Yieldez.
Neurotransmissions in the Central Nervous System Prof. Alhaider.
 Parkinson’s disease is a neurodegenerative disorder first described by Dr James Parkinson, a London physician, in The underlying cause is loss.
Neurochemistry of executive functions
How Do Drugs Affect Synapses? BY RUI XIAO. Psychoactive Drugs  Psychoactive drugs are chemical substances that can alter brain functions and result in.
Describe and Evaluate Biological Explanations for Schizophrenia.
Dopaminergic pathophysiology: hypothesis on RLS mechanisms Walter Paulus Göttingen Germany.
Other markers of dopamine function in CSF and serum of RLS Karin Stiasny-Kolster Department of Neurology Philipps University Marburg Germany.
Neurotransmitters.
Module 7.3 Movement Disorders
Eric Niederhoffer SIU-SOM
Network interactions in schizophrenia — therapeutic implications
By the end of this section you will be able to …..
BIOLOGY AND CRIMINAL BEHAVIOR
Pharmacology of central Neurotransmitters Prof. Yieldez Bassiouni
Treatment of Parkinson’s disease
DOPAMINE HYPOTHESIS.
Chapter 7. Pharmacology and Biochemistry of Synaptic Transmission: Classical Transmitters Copyright © 2014 Elsevier Inc. All rights reserved.
postsynaptic receptors
Seratonin and Dopamine in the CNS
Neurotransmitters (NT)
Neuro-imaging applications in Psychiatry
Figure 2 Monoamine synthesis and metabolism in neurons
Neurotransmitters.
Chapter 12 Mood Disorders and Depression
Acetylcholine synthesis
Parkinson's Disease Neuron
Neurotransmitters.
Raymond T Bartus, Marc S Weinberg, R. Jude Samulski  Molecular Therapy 
Presentation transcript:

Uppsala University PET Centre Per Hartvig, Uppsala University PET Centre Central dopaminergic and serotonergic function studied with positron emission tomography

Uppsala University PET Centre ´ Biosynthesis of dopamine and serotonin Precursor amino acid (tyrosine, tryptophan) Hydroxylase (tetrahydrobiopterin)  L-dopa or 5-hydroxytryptophan Aromatic amino acid decarboxylase (pyridoxine, vitamin B 6 )  Dopamine or serotonin

Uppsala University PET Centre Effect of the the dopamine D2 antagonist OSU6162 Dopamine synthesis rate, k 3, min -1 in Rhesus monkeys before and after 3 mg/kg of OSU 6162.

Uppsala University PET Centre Effect of tyrosine and R-tetrahydrobiopterin on dopamine synthesis rate and stabilization with OSU 6162 Tyrosine and biopterin increases dopamine synthesis rate The increased rate is stabilized to baseline by OSU6162

Uppsala University PET Centre Clinical studies using OSU6162 Parkinson disease Huntington chorea Schizophrenia (Alcoholism, smoking cessation)

Uppsala University PET Centre Apomorphine effect on dopamine synthesis rate, k 3

Uppsala University PET Centre ”Tune” dependent change of dopamine synthesis rate Apomorphine 0.1 mg/kg induced decrease of dopa- mine change is dependent on baseline dopamine tuning in the Rhesus monkey

Uppsala University PET Centre Effect of L-DOPA in early and advanced Parkinsons disease L-DOPA infusion saturates dopamine synthesis in early Parkinson´s disease In advanced disease a loss of presynaptic dopamine receptors explains the induction of rate

Uppsala University PET Centre Is L-DOPA an endogenous neurotransmitter ? (Miwa, Goishima 1993) L-DOPA infusion 3 or 15 mg/kg/h induces an increase in dopamine synthesis rate.

Uppsala University PET Centre Effect of 5R-erythro-tetrahydro- biopterin on dopamine synthesis 6R-erythro-5,5,7,8 tetra- hydrobiopterin, the endo- genous cofactor for the hydroxylases induces an increased dopamine synthesis rate

Uppsala University PET Centre 6R-erythro-5,6,7,8-tetrahydrobiopterin Pharmacological effects –Release of monoamines and serotonin –Receptor effects –Enhances synthesis of monoamines – Hydroxylase AADC –Tyrosine  L-DOPA  Dopamine – Biopterin,BH4 Pyridoxin

Uppsala University PET Centre Clinical studies –Infantil autistic disorder –(Double blind 3 mg/kg cross over, randomized study in children 4-8 y with PET, neurochemistry, immunology and clinical evaluation) –Parkinson´s disease –Alzheimer´s disease 6R-erythro-5,6,7,8-tetrahydrobiopterin

Uppsala University PET Centre The importance of radiolabelling position, 11 C Dopa vs 18 F-fluoro-dopa No effect of tetrahydrobiopterin due to increased synthesis of 3-O-methyl dopa which is Passing to the brain giving increased background radioactivity in the reference

Uppsala University PET Centre Multitracer protocol on dopamine function in toxicology Toxic Dopamine Presynaptic Postsynaptic reaction synthesis terminals terminals MPTP   (  ) Manganese    Wilson    disease

Uppsala University PET Centre Regulation of presynaptic dopamine function Supply of tyrosine and L-DOPA L-DOPA catalysing effect on synthesis Tetrahydrobiopterin effects on synthesis and release Presynaptic control in Parkinson disease Tune dependent control Dopamine stabilisers

Uppsala University PET Centre Radiotracers used with PET for studies on presynaptic serotonin [  - 11 C]L-tryptophan Carboxy - [ 11 C]L-tryptophan 5-hydroxy- [  - 11 C]L-tryptophan [ 11 C] -  -methyl-L-tryptophan

Uppsala University PET Centre Brain serotonin synthesis CH 3

Uppsala University PET Centre Positron emission tomography 11 C-Tryptophan 5-hydroxy- 11 C-tryptophan

Uppsala University PET Centre Brain utilization rate 5-Hydroxi (  - 11 C)tryptophan 11 C-tryptophan SUV Time to peak 15 min 15 min Rate Striatum 7.0 x x Frontal ctx Temp ctx ______________________________________________________________________________ 11 C-TRP give insignificant 11 C-HT during PET, but might show some specific uptake of the tracer

Uppsala University PET Centre Endogenous tracer substrates Uptake into the target tissue, passing over the BBB Regional tissue accumulation of tracer Uptake into target cells Complex with enzymes in target cells Formation of active transmitter Uptake of active transmitter Release of transmitter to the synapse Binding to target receptors Metabolism of transmitter with cumulation

Uppsala University PET Centre Biosynthesis of dopamine and serotonin Precursor amino acid (tyrosine, tryptophan) Hydroxylase (tetrahydrobiopterin)  L-dopa or 5-hydroxytryptophan Aromatic amino acid decarboxylase (pyridoxine, vitamin B 6 )  Dopamine or serotonin

Uppsala University PET Centre Effect of pyridoxine on the decarboxylation rate of 5-hydroxytryptophan

Uppsala University PET Centre Selectivity of aromatic amino acid decarboxylase Treatment Decarboxylation rate, K 3 of L-DOPA 5-hydroxitryptophan ______________________________________________ Pyridoxine 10 mg bolus 0 + Tetrahydrobiopterin 1 –15 mg/kg/h + 0

Uppsala University PET Centre Effect of bolus doses of amino acid on decarboxylation rate of L-DOPA and 5-HTP

Uppsala University PET Centre Factors regulating uptake of amino acids to the brain and neurotransmitter synthesis Plasma amino acids Diurnal rythm Age Gender Food and drinking –Proteins, carbohydrates and fat –Caffeine, ethanol Co-factors and vitamins (Pyridoxin B6, biopterin) Drugs, SSRI

Uppsala University PET Centre Effect of glucose infusion on uptake of 5- hydroxytryptophan derived radioactivity

Uppsala University PET Centre Cerebral presynaptic synthesis in depression

Uppsala University PET Centre Decarboxylation rate of 5-HTP in different brain areas Area ControlsDepressed __________________________________________________ Lateral frontal cortex min Medial frontal cortex high low0.0001* Caudate Putamen ________________________________________________

Uppsala University PET Centre Brain disposition of precursor amino acids Disease SUV Synthesis rate Sex F > M Depression  Med pre frt ctx  Schizophrenia  Do, ganglia  Tourette  ganglia  OCD  ganglia  ECT 

Uppsala University PET Centre Presynaptic serotonin function in social phobia ( Ina Marteinsdottir et al 2001) Method: Statistical evaluation of PET with 5-hydroxy- tryptophan by a pixel wise blocked analysis of variance contrasting differences between patients and controls. Results: A a focal hyposerotonergic tonus in social phobics as compared to controls was evident in temporal cortex (periamygdala/rhinal, temporal pole and gyrus); frontal cortex, anterior cingulatae, right insula and left basal ganglia.

Uppsala University PET Centre Regulation of aromatic amino acid decarboxylase activity for L-DOPA and 5-hydroxytryptophan Several mechanisms regulate amino acid transport to the brain and presynaptic synthesis serotonin Synthesis of serotonin may be regulated by a similar decarboxylase enzyme but with different selectivity Modulating effect of enzyme co-factors e.g. tetrahydrobiopte- rin and vitamin B6 varied for the two transmitters Capacity limitation in transport and enzyme activity for 5HTP Limited capacity of amino acid transport may influence serotonin function with special impact in affective disorders

Uppsala University PET Centre What is measured with 5-HTP and PET ? 11 C-labelling in carboxy and  -position of 5-HTP Blockade of central decarboxylase with NSD1015 Bioanalysis of brain radioactivity using rat brain homogenate by HPLC shows radiolabelled 5-HTP, serotonin and metabolites Calculated rates analysed of brain radioactivity in rat brain are similar to rates measured in monkey and man with 5-HTP and PET

Uppsala University PET Centre Calculation of decarboxylation rate Brain reference region after validation of accumulation (Patlack plot, Hartvig et al 1992) Simulation of a brain refrence region with negligable 5HT synthesis gives rates close to measured (Blomquist et al 2001) Plasma as reference with metabolite correction shows regional 5HT rates in accordance with AADC activity (Hagberg et al JBFM, 2002)

Uppsala University PET Centre Rapid in vivo metabolism to radiolabelled products Low plasma concentration of radioactivity Serotonergic activity in most brain areas - no obvious reference area in the brain Steady state in the brain not established in min Limited capacity for transport over BBB and for synthesis Use of tracer may occur in non-serotonergic neurons Limitations in studies with 5-hydroxy [ 11 C]tryptophan

Uppsala University PET Centre Theses at UUPC Peter BjurlingRadiosynthesis Lars Reibring-Depression Joakim TedroffL-Dopa in PD Karl Johan Lindner Validation of 5 HTP Anna EkesboDA degeneration, OSU Richard Torstenson Regulation of DA Ina MarteinsdottirSSRI responsive diseases Pinelopi Merachtsaki Regulation of serotonin